http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2012148818-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-553 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D267-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D267-10 |
| filingDate | 2011-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2012148818-A |
| titleOfInvention | 2,5,6,7-TETRAHYDRO- [1,4] OKSAZEPIN-3-ILMAIN OR 2,3,6,7-TETRAHYDRO- [1,4] OKSAZEPIN-5-ILAMINE |
| abstract | 1. Compounds of the formula wherein A is O and B is —CRR—; or B is O and A is -CRR-; R is selected from the group consisting of hydrogen, C-alkyl and C-cycloalkyl; R is selected from the group consisting of hydrogen, C-alkyl and C-cycloalkyl; R is selected from the group consisting of from hydrogen, halogen, C-alkyl and C-cycloalkyl; R is selected from the group consisting of hydrogen, halogen, C-alkyl and C-cycloalkyl; R is C-alkyl or C-cycloalkyl; or R and R together with the C atom to which they are attached to form a cyclopropyl ring; R, R, R and R are independently selected from the group consisting of hydrogen, C-alkyl , halogen and halogen-C-alkyl; R is - (CO) -R or R, where R is selected from the group consisting of isaryl, wherein said aryl is unsubstituted or substituted by one, two or three groups selected from the group consisting of C-alkyl, halogen, halogen-C-alkyl, C-alkoxy, halogen-C-alkoxy, cyano, hydroxy-C-alkyl, oxo and phenyl, heteroaryl, wherein said heteroaryl is unsubstituted or substituted by one, two or three groups selected from the group consisting of C-alkyl, halogen, halogen-C-alkyl, C-alkoxy, halogen-C-alkoxy, cyano, hydroxy-C-alkyl, oxo and f nyl, C-alkyl, halogen-C-alkyl, C-cycloalkyl, wherein said cycloalkyl is unsubstituted or substituted by one, two, three or four groups selected from the group consisting of C-alkyl, halogen or halogen-C-alkyl, C-alkoxy-C-alkyl; R is selected from the group consisting of C-alkyl and C-cycloalkyl, said cycloalkyl being unsubstituted or substituted by one, two, three or four groups selected from the group consisting of C-alkyl, halogen and halogen- C-alkyl, R and R independently |
| priorityDate | 2010-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 300.